FERROUS SULFATE REDUCES LEVODOPA BIOAVAILABILITY - CHELATION AS A POSSIBLE MECHANISM

被引：34
作者：
CAMPBELL, NRC
HASINOFF, B
机构：
[1] MEM UNIV NEWFOUNDLAND,DEPT CHEM,ST JOHNS A1C 5S7,NEWFOUNDLAND,CANADA
[2] MEM UNIV NEWFOUNDLAND,DISCIPLINE MED,ST JOHNS A1C 5S7,NEWFOUNDLAND,CANADA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 45卷 / 03期
关键词：
D O I：
10.1038/clpt.1989.21
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：220 / 225
页数：6
相关论文
共 15 条
[1]  
ABD E, 1984, ANAL LETT, V17, P205
[2]   COORDINATION CHEMISTRY OF MICROBIAL IRON TRANSPORT COMPOUNDS .9. STABILITY-CONSTANTS FOR CATECHOL MODELS OF ENTEROBACTIN [J].
AVDEEF, A ;
SOFEN, SR ;
BREGANTE, TL ;
RAYMOND, KN .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1978, 100 (17) :5362-5370
[3]   ALTERATION OF METHYLDOPA ABSORPTION, METABOLISM, AND BLOOD-PRESSURE CONTROL CAUSED BY FERROUS SULFATE AND FERROUS GLUCONATE [J].
CAMPBELL, N ;
PADDOCK, V ;
SUNDARAM, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (04) :381-386
[4]   SYSTEMIC AVAILABILITY OF ORALLY-ADMINISTERED L-DOPA IN THE ELDERLY PARKINSONIAN PATIENT [J].
EVANS, MA ;
TRIGGS, EJ ;
BROE, GA ;
SAINES, N .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (03) :215-221
[5]  
GERGELY A, 1979, MET IONS BIOL SYST, V9, P143
[6]  
GOLDSTEIN DS, 1984, CLIN CHEM, V30, P815
[7]   THE PHARMACOKINETICS OF INTRAVENOUS AND ORAL LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE WHO EXHIBIT ON-OFF FLUCTUATIONS [J].
HARDIE, RJ ;
MALCOLM, SL ;
LEES, AJ ;
STERN, GM ;
ALLEN, JG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (04) :429-436
[8]  
HILLMAN RS, 1985, GOODMAN GILMANS PHAR, P1308
[9]   DIET AND UPTAKE OF ALDOMET BY BRAIN - COMPETITION WITH NATURAL LARGE NEUTRAL AMINO-ACIDS [J].
MARKOVITZ, DC ;
FERNSTROM, JD .
SCIENCE, 1977, 197 (4307) :1014-1015
[10]   INTERACTIONS OF FE(III) WITH ADRENALINE, L-DOPA AND OTHER CATECHOL DERIVATIVES - EQUILIBRIA AND KINETICS OF COMPLEX-FORMATION IN ACIDIC PERCHLORATE MEDIA [J].
MENTASTI, E ;
PELIZZETTI, E ;
SAINI, G .
JOURNAL OF INORGANIC & NUCLEAR CHEMISTRY, 1976, 38 (04) :785-788
12